Results 81 to 90 of about 222,329 (311)
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber +7 more
wiley +1 more source
Automated Identification of Drug-Drug Interactions in Pediatric Congestive Heart Failure Patients [PDF]
Daniel Miller
openalex +1 more source
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen +8 more
wiley +1 more source
Peritoneal dialysis in congestive heart failure
Heart failure is a major and growing health problem. There have been major advances in the understanding of pathophysiology of heart failure as a chronic progressive disorder, which has led to newer therapies.
Abirami Krishnan, D.G. Oreopoulos
doaj +1 more source
Tissue Doppler imaging in patients with congestive heart failure and conduction disorders [PDF]
Lothar Faber
openalex +1 more source
External validation of the BAN‐ADHF diuretic‐resistance score in the DAPA‐RESIST clinical trial
Diuretic resistance in worsening heart failure (HF) is associated with poorer outcomes and, although common, can be challenging to identify. The recently developed BAN‐ADHF score can potentially identify patients with worsening HF at risk of diuretic resistance.
Dominic M. Alfonso +10 more
wiley +1 more source
The efficacy and safety of Tolvaptan on treating congestive heart failure patients with hyponatremia [PDF]
L. Ling, Z. Wen-ling, Bai Hua
openalex +1 more source
Multifunctional nano‐networks (NNWs) are prepared via reaction‐induced self‐assembly (RISA) of spermidine (SPD), epigallocatechin gallate (EGCG), 2‐formylphenylboronic acid (2‐FPBA), and deferoxamine (DFO) through dynamic iminoboronate bonds. These NNWs leverage the oxidative AKI microenvironment to trigger disintegration, enabling site‐specific ...
Juan Jin +17 more
wiley +1 more source

